Our data demonstrate that IDH2 was significantly downregulated in early stage (in situ carcinoma) and upregulated in advanced stage (infiltrating carcinoma) colon cancer compared to peritumor tissue (Fig. 1). This evidence concerns the gene IDH2 and in situ carcinoma.